Innovation Archive — Page 7 of 8

December 9, 2021

Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

By Bill Snyder
December 2, 2021

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

By Bill Snyder
From left, Dandan Liu, PhD, Alan Storrow, MD, and Sunil Kripalani, MD, MSc, are testing the real-world implementation of a risk stratification tool to avoid unnecessary hospital admissions of patients diagnosed with acute heart failure in the emergency department.
November 11, 2021

VUMC team puts tool to reduce heart failure admissions to test

Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.

By Bill Snyder
May 18, 2021

Rosenbloom appointed to National Library of Medicine’s Biomedical Informatics, Library and Data Sciences Review Committee

Trent Rosenbloom, MD, MPH, professor and vice chair of Faculty Affairs in the Department of Biomedical Informatics, has been appointed to the National Library of Medicine’s (NLM) Biomedical Informatics, Library and Data Sciences (BILDS) Review Committee.

By Mia Garchitorena-Scancarelli
VUMC’s REDCap team helped the Washington State Department of Health ramp up its COVID-19 drive-through testing capabilities. Above, testing is performed in Everett, Washington, in March.
September 24, 2020

REDCap helps state of Washington scale up its testing capacity

Until it was eclipsed by New York in mid-April, the state of Washington had the highest absolute number of COVID-19 cases in the United States.

By Bill Snyder
A VUMC study found that following up with patients within the week after their hospital discharge as a stand-alone intervention has no impact on readmissions, mortality or patient satisfaction.
September 24, 2020

Follow-up calls don’t impact readmission, mortality rates: study

Following up with adult general medicine patients by phone within the week after their hospital discharge as a stand-alone intervention has no impact on readmissions, mortality or patient satisfaction, according to a new study by Vanderbilt University Medical Center researchers.

By Kelsey Herbers